Karoliina Wehkalampi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Karoliina Wehkalampi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Leo Dunkel
Queen Mary University of London
7 shared publications Michael Barnes
6 shared publications- Sasha Rose Howard
Centre for Endocrinology, William Harvey Research Institute Queen Mary University of London London UK
6 shared publications Claudia Cabrera
5 shared publicationsHelen Storr
5 shared publicationsHelen Warren
4 shared publications
Latest Publications
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in HS6ST1 cause self-limited delayed puberty (DP) in addition to idiopathic hypogonadotropic hypogonadism (IHH)
Background: Self-limited DP often segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. By comparison, many genes have been identified where loss-of-function mutations lead to IHH. Despite likely overlap between the pathophysiology of DP and conditions of GnRH deficiency, few studies have examined the contribution of mutations in IHH genes to the phenotype of DP. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with DP. We filtered the results, seeking potentially pathogenic mutations, with a list of 25 genes identified in the published literature as causal in IHH. After follow-up targeted re-sequencing in a further 42 families (288 individuals), one candidate gene was identified. Developmental tissue expression studies and assessment of the enzymatic function of the mutant protein were performed. Results: A rare variant in HS6ST1 (Heparan sulfate 6-O sulphotransferase i) was identified, present in six affected members in one family and not present in 145 controls. No other pathogenic variants in IHH genes were identified. HS6ST1 codes for an enzyme that modifies extracellular matrix components critical for normal neural branching. It is thought to be required for the function of FGFR1 and KAL1 in vivo, both of which are vital for GnRH neuronal development and normal hypothalamic-pituitary-gonadal axis function. Our variant is predicted to lie within a highly conserved coiled-coil domain and displays reduced sulphotransferase activity in vitro. Conclusions: Mutations in HS6ST1 contribute to the phenotype of both IHH and DP. Thus, it appears that misregulation of GnRH neuronal migration and differentiation may cause both IHH and DP. However, the overlap in the genetic basis for these two conditions appears from our study to date to be limited to a subset of IHH genes.
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in HS6ST1 cause self-limited delayed puberty (DP) in addition to idiopathic hypogonadotropic hypogonadism (IHH)
Background: Self-limited DP often segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. By comparison, many genes have been identified where loss-of-function mutations lead to IHH. Despite likely overlap between the pathophysiology of DP and conditions of GnRH deficiency, few studies have examined the contribution of mutations in IHH genes to the phenotype of DP. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with DP. We filtered the results, seeking potentially pathogenic mutations, with a list of 25 genes identified in the published literature as causal in IHH. After follow-up targeted re-sequencing in a further 42 families (288 individuals), one candidate gene was identified. Developmental tissue expression studies and assessment of the enzymatic function of the mutant protein were performed. Results: A rare variant in HS6ST1 (Heparan sulfate 6-O sulphotransferase i) was identified, present in six affected members in one family and not present in 145 controls. No other pathogenic variants in IHH genes were identified. HS6ST1 codes for an enzyme that modifies extracellular matrix components critical for normal neural branching. It is thought to be required for the function of FGFR1 and KAL1 in vivo, both of which are vital for GnRH neuronal development and normal hypothalamic-pituitary-gonadal axis function. Our variant is predicted to lie within a highly conserved coiled-coil domain and displays reduced sulphotransferase activity in vitro. Conclusions: Mutations in HS6ST1 contribute to the phenotype of both IHH and DP. Thus, it appears that misregulation of GnRH neuronal migration and differentiation may cause both IHH and DP. However, the overlap in the genetic basis for these two conditions appears from our study to date to be limited to a subset of IHH genes.
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty
Background: Abnormal pubertal timing affects over 4% of adolescents and is associated with adverse health and psychosocial outcomes. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. However, despite this strong heritability, little is known about the genetic control of human puberty. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. Methods: We performed whole exome sequencing in 52 members of seven families from our patient cohort with DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. The functional consequences of the identified mutations in one candidate gene were interrogated via expression of WT and mutant proteins in mammalian cells. For this gene we defined tissue expression in human and mouse embryos by in situ hybridization and immunohistochemistry. The effects of gene knockdown were investigated via in vitro neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently labeled GnRH neurons. Results: We identified four rare mutations in IGSF10 in ten unrelated families, which are tightly associated with the DP trait within our cohort (P=3.47×10−4). The identified mutations are in evolutionarily conserved positions, and two mutations result in intracellular retention with failure in secretion of the N-terminal fragment of the protein. IGSF10 mRNA is strongly expressed in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the zebrafish model. Conclusions: We present our novel finding that mutations in IGSF10 cause delayed puberty in humans, through misregulation of GnRH neuronal migration during embryonic development.
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty
Background: Abnormal pubertal timing affects over 4% of adolescents and is associated with adverse health and psychosocial outcomes. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. However, despite this strong heritability, little is known about the genetic control of human puberty. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. Methods: We performed whole exome sequencing in 52 members of seven families from our patient cohort with DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. The functional consequences of the identified mutations in one candidate gene were interrogated via expression of WT and mutant proteins in mammalian cells. For this gene we defined tissue expression in human and mouse embryos by in situ hybridization and immunohistochemistry. The effects of gene knockdown were investigated via in vitro neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently labeled GnRH neurons. Results: We identified four rare mutations in IGSF10 in ten unrelated families, which are tightly associated with the DP trait within our cohort (P=3.47×10−4). The identified mutations are in evolutionarily conserved positions, and two mutations result in intracellular retention with failure in secretion of the N-terminal fragment of the protein. IGSF10 mRNA is strongly expressed in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the zebrafish model. Conclusions: We present our novel finding that mutations in IGSF10 cause delayed puberty in humans, through misregulation of GnRH neuronal migration during embryonic development.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in HS6ST1 are causal in self-limited delayed puberty as well as idiopathic hypogonadotropic hypogonadism
Background: Self-limited delayed puberty (DP) often segregates in an autosomal dominant pattern, suggesting that inheritance is conferred by a small number of genes. However, the underlying genetic background is mostly unknown. By comparison, many genes have been identified where loss-of-function mutations lead to hypogonadotropic hypogonadism (HH). Despite likely overlap between the pathophysiology of delayed puberty and conditions of GnRH deficiency, few studies have examined the contribution of mutations in HH genes to the phenotype of DP. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with DP. We filtered the results, seeking potentially pathogenic mutations, with a list of 25 genes identified in the published literature as causal in HH. After follow-up targeted re-sequencing in a further 42 families (288 individuals), one candidate gene was identified. Developmental tissue expression studies and assessment of the enzymatic function of the mutant protein were carried out. Results: A rare variant in HS6ST1 (Heparan sulfate 6-O sulphotransferase 1) was identified, present in six affected members of one family and not present in 145 controls. No other pathogenic variants in HH genes were identified. HS6ST1 codes for an extracellular matrix component critical for normal neural branching. It is thought to be required for the function of FGFR1 and KAL1 in vivo, both of which are vital for GnRH neuronal development and normal hypothalamic–pituitary–gonadal axis function. The novel variant was predicted to lie within a highly conserved coiled-coil domain and displayed reduced sulphotransferase activity in vitro. Conclusions: Mutations in HS6ST1 contribute to the phenotype of DP. However, although mutations in genes controlling GnRH neuronal migration and differentiation may cause both HH and DP, the overlap in the genetic basis for the two conditions appears from our study to date to be limited to a subset of HH genes.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in HS6ST1 are causal in self-limited delayed puberty as well as idiopathic hypogonadotropic hypogonadism
Background: Self-limited delayed puberty (DP) often segregates in an autosomal dominant pattern, suggesting that inheritance is conferred by a small number of genes. However, the underlying genetic background is mostly unknown. By comparison, many genes have been identified where loss-of-function mutations lead to hypogonadotropic hypogonadism (HH). Despite likely overlap between the pathophysiology of delayed puberty and conditions of GnRH deficiency, few studies have examined the contribution of mutations in HH genes to the phenotype of DP. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with DP. We filtered the results, seeking potentially pathogenic mutations, with a list of 25 genes identified in the published literature as causal in HH. After follow-up targeted re-sequencing in a further 42 families (288 individuals), one candidate gene was identified. Developmental tissue expression studies and assessment of the enzymatic function of the mutant protein were carried out. Results: A rare variant in HS6ST1 (Heparan sulfate 6-O sulphotransferase 1) was identified, present in six affected members of one family and not present in 145 controls. No other pathogenic variants in HH genes were identified. HS6ST1 codes for an extracellular matrix component critical for normal neural branching. It is thought to be required for the function of FGFR1 and KAL1 in vivo, both of which are vital for GnRH neuronal development and normal hypothalamic–pituitary–gonadal axis function. The novel variant was predicted to lie within a highly conserved coiled-coil domain and displayed reduced sulphotransferase activity in vitro. Conclusions: Mutations in HS6ST1 contribute to the phenotype of DP. However, although mutations in genes controlling GnRH neuronal migration and differentiation may cause both HH and DP, the overlap in the genetic basis for the two conditions appears from our study to date to be limited to a subset of HH genes.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
Background: Timing of puberty is associated with height, cardiovascular health and cancer risk, with a significant public health impact. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but the underlying genetic background is unknown. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with self-limited DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. For one candidate gene we defined tissue expression in human and mouse embryos. The effects of gene knockdown were investigated via neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently-labelled GnRH neurons. N-terminal fragment mutations were interrogated via expression in mammalian cells. Results: We identified four rare heterozygous variants in IGSF10 in 29 members of ten unrelated families. All four variants were in evolutionarily conserved positions and were predicted by in silico analysis to have a deleterious effect on protein function. Statistical tests showed a significant difference in the prevalence of these mutations within DP cases compared to a general population (P=4.46×10−3), and a significant association between these mutations and the delayed puberty trait within our cohort (P=3.47×10−4). IGSF10 mRNA shows strong expression in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the transgenic zebrafish model. Reduced secretion of mutant protein was demonstrated by western blotting. Conclusions: We present our novel finding that IGSF10 mutations contribute to the phenotype of self-limited delayed puberty in humans, through impairment of migration of GnRH neurons during embryonic development.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
Background: Timing of puberty is associated with height, cardiovascular health and cancer risk, with a significant public health impact. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but the underlying genetic background is unknown. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with self-limited DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. For one candidate gene we defined tissue expression in human and mouse embryos. The effects of gene knockdown were investigated via neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently-labelled GnRH neurons. N-terminal fragment mutations were interrogated via expression in mammalian cells. Results: We identified four rare heterozygous variants in IGSF10 in 29 members of ten unrelated families. All four variants were in evolutionarily conserved positions and were predicted by in silico analysis to have a deleterious effect on protein function. Statistical tests showed a significant difference in the prevalence of these mutations within DP cases compared to a general population (P=4.46×10−3), and a significant association between these mutations and the delayed puberty trait within our cohort (P=3.47×10−4). IGSF10 mRNA shows strong expression in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the transgenic zebrafish model. Reduced secretion of mutant protein was demonstrated by western blotting. Conclusions: We present our novel finding that IGSF10 mutations contribute to the phenotype of self-limited delayed puberty in humans, through impairment of migration of GnRH neurons during embryonic development.
- 1 March 2014
- Published by Bioscientifica in Endocrine Abstracts
A novel gene affecting the timing of puberty
Background: Disturbances of pubertal timing affect >4% of the population and are associated with adverse health outcomes. Studies estimate 60–80% of variation in pubertal onset is genetically determined, but few genetic factors are known. We hypothesise that causal variants will be low-frequency, intermediate-impact variants and will be enriched in populations at the extremes of normal pubertal timing. Families with constitutional delay in growth and puberty (CDGP) have pubertal onset delayed by >2 S.D., often with an apparent autosomal dominant inheritance pattern. Methods: Seven highly informative families from our large, accurately phenotyped CDGP cohort were selected for whole exome sequencing. Annotation and filtering of variants produced an extensive list of potential causative mutations that segregate with trait. Variants were ranked on the basis of presence in greater than one family, minor allele frequency 0.8) with loci identified by genome-wide association studies (GWAS) of age-at-menarche. Results: The 15 top-ranking genes identified all contained non-synonymous missense variants segregating an autosomal dominant pattern. Validation of these 15 genes through targeted re-sequencing in a further 288 CDGP individuals has identified a novel candidate gene, with variants in nine families. This gene has a predicted role in neural outgrowth and is expressed in nasal placode mesenchyme during embryogenesis, suggesting a possible function in GnRH neuronal development. Minimal overlap with GWAS loci was identified. Functional studies of these novel variants are in progress. Discussion: We describe our strategy for identification of novel causal gene variants from next-generation sequencing data in this common condition. In addition to the exciting finding of a novel gene implicated in the timing of puberty, our results highlight the significant genetic heterogeneity seen in CDGP.
- 1 March 2014
- Published by Bioscientifica in Endocrine Abstracts
A novel gene affecting the timing of puberty
Background: Disturbances of pubertal timing affect >4% of the population and are associated with adverse health outcomes. Studies estimate 60–80% of variation in pubertal onset is genetically determined, but few genetic factors are known. We hypothesise that causal variants will be low-frequency, intermediate-impact variants and will be enriched in populations at the extremes of normal pubertal timing. Families with constitutional delay in growth and puberty (CDGP) have pubertal onset delayed by >2 S.D., often with an apparent autosomal dominant inheritance pattern. Methods: Seven highly informative families from our large, accurately phenotyped CDGP cohort were selected for whole exome sequencing. Annotation and filtering of variants produced an extensive list of potential causative mutations that segregate with trait. Variants were ranked on the basis of presence in greater than one family, minor allele frequency 0.8) with loci identified by genome-wide association studies (GWAS) of age-at-menarche. Results: The 15 top-ranking genes identified all contained non-synonymous missense variants segregating an autosomal dominant pattern. Validation of these 15 genes through targeted re-sequencing in a further 288 CDGP individuals has identified a novel candidate gene, with variants in nine families. This gene has a predicted role in neural outgrowth and is expressed in nasal placode mesenchyme during embryogenesis, suggesting a possible function in GnRH neuronal development. Minimal overlap with GWAS loci was identified. Functional studies of these novel variants are in progress. Discussion: We describe our strategy for identification of novel causal gene variants from next-generation sequencing data in this common condition. In addition to the exciting finding of a novel gene implicated in the timing of puberty, our results highlight the significant genetic heterogeneity seen in CDGP.
- Open Access
- 30 April 2013
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 12 (1) , 57
Lipoprotein subclass profiles in young adults born preterm at very low birth weight
Background: Adults born preterm at very low birth weight (VLBW ≤ 1500g) have increased risk factors for cardiovascular diseases including high blood pressure and impaired glucose regulation. Non-optimal lipoprotein profile is generally also likely to affect the increased cardiovascular risk, but lipoprotein subclass level data on adults born at VLBW are sparse. Subjects and methods: We studied 162 subjects born at VLBW and 169 term-born controls, aged 19 to 27 years. Total lipid, triglyceride and cholesterol concentrations of 14 lipoprotein subclasses were determined by proton nuclear magnetic resonance spectroscopy in the fasting state and in 2-hour serum samples from an oral glucose tolerance test. Findings: In comparison to controls, VLBW subjects had significantly higher fasting concentration of triglycerides in chylomicrons and largest very-low-density lipoprotein particles [XXL-VLDL-TG, difference 0.026 (95% CI: 0.004 to 0.049), P = 0.024], and of triglycerides in small high-density lipoprotein particles [S-HDL-TG, 0.026 (95% CI: 0.002 to 0.051), P = 0.037]. The seemingly important role of triglycerides was further supported by principal component analysis in which the first component was characterized by multiple lipoprotein triglyceride measures. Conclusions: Young adults born at VLBW and their peers born at term had triglyceride-related differences in both VLDL and HDL subclasses. These differences suggest that the increased risk factors for cardiovascular diseases among the VLBW individuals in adulthood may partly relate to impaired triglyceride metabolism.
- 30 April 2013
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 12 (1) , 57
Open AccessLipoprotein subclass profiles in young adults born preterm at very low birth weight
Background: Adults born preterm at very low birth weight (VLBW ≤ 1500g) have increased risk factors for cardiovascular diseases including high blood pressure and impaired glucose regulation. Non-optimal lipoprotein profile is generally also likely to affect the increased cardiovascular risk, but lipoprotein subclass level data on adults born at VLBW are sparse. Subjects and methods: We studied 162 subjects born at VLBW and 169 term-born controls, aged 19 to 27 years. Total lipid, triglyceride and cholesterol concentrations of 14 lipoprotein subclasses were determined by proton nuclear magnetic resonance spectroscopy in the fasting state and in 2-hour serum samples from an oral glucose tolerance test. Findings: In comparison to controls, VLBW subjects had significantly higher fasting concentration of triglycerides in chylomicrons and largest very-low-density lipoprotein particles [XXL-VLDL-TG, difference 0.026 (95% CI: 0.004 to 0.049), P = 0.024], and of triglycerides in small high-density lipoprotein particles [S-HDL-TG, 0.026 (95% CI: 0.002 to 0.051), P = 0.037]. The seemingly important role of triglycerides was further supported by principal component analysis in which the first component was characterized by multiple lipoprotein triglyceride measures. Conclusions: Young adults born at VLBW and their peers born at term had triglyceride-related differences in both VLDL and HDL subclasses. These differences suggest that the increased risk factors for cardiovascular diseases among the VLBW individuals in adulthood may partly relate to impaired triglyceride metabolism.
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Familial constitutional delay in growth and puberty is a condition with significant genetic heterogeneity and limited overlap with the timing of puberty in the general population
Background: Pubertal timing has importance both for the individual, but also for public health. Previous studies estimate that 60–80% of variation in pubertal onset is genetically determined. Recently, a large genome-wide association study (GWAS) meta-analysis identified 42 loci for age-at-menarche (AAM), which explained 3.6–6.1% of the variation in the general population, but causal genes have not been identified. CDGP is defined as pubertal onset at more than 2.0 standard deviations later than mean population age. CDGP therefore represents an extreme variant of normal pubertal timing and has repeatedly been shown to cluster in families, but the genetic factors behind CDGP remain elusive. Aims: We hypothesise that in CDGP only a few genetic variants have a strong impact on the timing of puberty, and we aim to identify these using whole exome sequencing (WES). Methods/Results: We selected seven very informative CDGP families who have been accurately phenotyped through long-term growth data. Filtering and annotation of over 2 million variants returned from WES of 52 individuals produced an extensive list of potential causative variants that segregate with the trait. No common gene mutations were apparent across the seven families, and pathway analysis did not identify common pathways across the families. To examine for genetic overlap between causal genes in CDGP, and AAM in the normal population, we identified all genes in linkage disequilibrium with the GWAS loci with inclusive limits (D′>0.8, r2 no limit, altogether 297 genes). Nine variants were seen in these 297 genes in our CDGP patients, all known non-synonymous single nucleotide polymorphisms. Sequencing of the nine genes in a further 288 CDGP individuals is currently underway for validation. Discussion: Our results highlight the significant genetic heterogeneity in CDGP, and suggest limited overlap between the genetic factors regulating pubertal timing in the normal population and CDGP. Declaration of funding: This work was supported by the Barts and the London Charity (grant number 417/1551) and the Academy of Finland (grant number 14135).
- 1 March 2013
- Published by Bioscientifica in Endocrine Abstracts
- p. 1
Familial constitutional delay in growth and puberty is a condition with significant genetic heterogeneity and limited overlap with the timing of puberty in the general population
Background: Pubertal timing has importance both for the individual, but also for public health. Previous studies estimate that 60–80% of variation in pubertal onset is genetically determined. Recently, a large genome-wide association study (GWAS) meta-analysis identified 42 loci for age-at-menarche (AAM), which explained 3.6–6.1% of the variation in the general population, but causal genes have not been identified. CDGP is defined as pubertal onset at more than 2.0 standard deviations later than mean population age. CDGP therefore represents an extreme variant of normal pubertal timing and has repeatedly been shown to cluster in families, but the genetic factors behind CDGP remain elusive. Aims: We hypothesise that in CDGP only a few genetic variants have a strong impact on the timing of puberty, and we aim to identify these using whole exome sequencing (WES). Methods/Results: We selected seven very informative CDGP families who have been accurately phenotyped through long-term growth data. Filtering and annotation of over 2 million variants returned from WES of 52 individuals produced an extensive list of potential causative variants that segregate with the trait. No common gene mutations were apparent across the seven families, and pathway analysis did not identify common pathways across the families. To examine for genetic overlap between causal genes in CDGP, and AAM in the normal population, we identified all genes in linkage disequilibrium with the GWAS loci with inclusive limits (D′>0.8, r2 no limit, altogether 297 genes). Nine variants were seen in these 297 genes in our CDGP patients, all known non-synonymous single nucleotide polymorphisms. Sequencing of the nine genes in a further 288 CDGP individuals is currently underway for validation. Discussion: Our results highlight the significant genetic heterogeneity in CDGP, and suggest limited overlap between the genetic factors regulating pubertal timing in the normal population and CDGP. Declaration of funding: This work was supported by the Barts and the London Charity (grant number 417/1551) and the Academy of Finland (grant number 14135).
- 29 June 2011
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 76 (2) , 130-135
Adult Height in Girls with Delayed Pubertal Growth
Background/Aims: Boys with constitutional delay of growth and puberty (CDGP) with early reduction in relative height before the onset of puberty will have adult height (AH) clearly below their target height (TH). Characteristics of growth in girls with CDGP are poorly known. We examined whether girls with CDGP attain their TH and whether early reduction in height SDS influences their AH. We also investigated effects of low-dose estrogen on AH. Methods: We investigated growth of 39 women (7 treated with low-dose estrogen) with CDGP history. We compared AH between estrogen-treated and untreated subjects, and used multiple linear regression to investigate the influence of various growth characteristics, e.g. height SDS changes between different ages in childhood, on AH. Results: AH was similar in estrogen-treated and untreated subjects. Reduction of height SDS between 3 and 8 years was significantly associated with the difference between AH and TH (regression coefficient 0.8, 95% confidence interval 0.1–1.5). Overall, 49% of subjects had AH >0.50 SDS below TH. Conclusion: A proportion of CDGP girls do not attain AH consistent with their TH. Reduction in height SDS in childhood predicts smaller AH. Low-dose estrogen treatment does not seem to influence AH in girls with CDGP.
- 29 June 2011
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 76 (2) , 130-135
Adult Height in Girls with Delayed Pubertal Growth
Background/Aims: Boys with constitutional delay of growth and puberty (CDGP) with early reduction in relative height before the onset of puberty will have adult height (AH) clearly below their target height (TH). Characteristics of growth in girls with CDGP are poorly known. We examined whether girls with CDGP attain their TH and whether early reduction in height SDS influences their AH. We also investigated effects of low-dose estrogen on AH. Methods: We investigated growth of 39 women (7 treated with low-dose estrogen) with CDGP history. We compared AH between estrogen-treated and untreated subjects, and used multiple linear regression to investigate the influence of various growth characteristics, e.g. height SDS changes between different ages in childhood, on AH. Results: AH was similar in estrogen-treated and untreated subjects. Reduction of height SDS between 3 and 8 years was significantly associated with the difference between AH and TH (regression coefficient 0.8, 95% confidence interval 0.1–1.5). Overall, 49% of subjects had AH >0.50 SDS below TH. Conclusion: A proportion of CDGP girls do not attain AH consistent with their TH. Reduction in height SDS in childhood predicts smaller AH. Low-dose estrogen treatment does not seem to influence AH in girls with CDGP.
- 1 February 2011
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (2) , 525-533
Advanced Pubertal Growth Spurt in Subjects Born Preterm: The Helsinki Study of Very Low Birth Weight Adults
Context: Among people born at term, low birth weight is associated with early puberty. Early maturation may be on the pathway linking low birth weight with cardiovascular disease and type 2 diabetes. Subjects born preterm with very low birth weight (VLBW; <1500 g) have as adults increased risk factors for cardiovascular disease. Little is known about their pubertal timing. Objective: The objective of the investigation was to study the timing of pubertal growth in subjects born preterm with VLBW as compared with controls. Design, Setting, and Participants: A follow-up study of subjects born preterm including 188 VLBW and 190 term-born control subjects. Growth data were available for 128 VLBW and 147 control subjects, of whom we excluded 15 and 1, respectively, because of neurological impairment. Main Outcome Measure: Timing of pubertal growth spurt was estimated by assessing the ages, corrected for gestational age at birth, at acceleration (take-off) and peak height velocity of pubertal growth, and age at attaining adult height. Results: All components of pubertal growth occurred earlier in VLBW subjects than in controls. Age at take-off was 0.8 yr earlier [95% confidence interval (CI) 0.4–1.3] in VLBW subjects born appropriate and 0.9 yr earlier (95% CI 0.4–1.5) in those born small for gestational age. VLBW subjects were more likely to have a pubertal growth spurt that was at least 2 yr earlier than population average [odds ratio 3.8 (95% CI: 1.5–9.6)]. Conclusions: Prematurity per se is associated with advanced pubertal growth. Advanced puberty may be among the factors mediating adult metabolic outcomes in subjects born preterm with VLBW.
- 1 February 2011
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (2) , 525-533
Advanced Pubertal Growth Spurt in Subjects Born Preterm: The Helsinki Study of Very Low Birth Weight Adults
Context: Among people born at term, low birth weight is associated with early puberty. Early maturation may be on the pathway linking low birth weight with cardiovascular disease and type 2 diabetes. Subjects born preterm with very low birth weight (VLBW; <1500 g) have as adults increased risk factors for cardiovascular disease. Little is known about their pubertal timing. Objective: The objective of the investigation was to study the timing of pubertal growth in subjects born preterm with VLBW as compared with controls. Design, Setting, and Participants: A follow-up study of subjects born preterm including 188 VLBW and 190 term-born control subjects. Growth data were available for 128 VLBW and 147 control subjects, of whom we excluded 15 and 1, respectively, because of neurological impairment. Main Outcome Measure: Timing of pubertal growth spurt was estimated by assessing the ages, corrected for gestational age at birth, at acceleration (take-off) and peak height velocity of pubertal growth, and age at attaining adult height. Results: All components of pubertal growth occurred earlier in VLBW subjects than in controls. Age at take-off was 0.8 yr earlier [95% confidence interval (CI) 0.4–1.3] in VLBW subjects born appropriate and 0.9 yr earlier (95% CI 0.4–1.5) in those born small for gestational age. VLBW subjects were more likely to have a pubertal growth spurt that was at least 2 yr earlier than population average [odds ratio 3.8 (95% CI: 1.5–9.6)]. Conclusions: Prematurity per se is associated with advanced pubertal growth. Advanced puberty may be among the factors mediating adult metabolic outcomes in subjects born preterm with VLBW.
- 19 April 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 157 (3) , 421-427.e1
Reduced Body Size and Shape-Related Symptoms in Young Adults Born Preterm with Very Low Birth Weight: Helsinki Study of Very Low Birth Weight Adults
- 19 April 2010
- Published by Elsevier in The Journal of Pediatrics
- Vol. 157 (3) , 421-427.e1
Reduced Body Size and Shape-Related Symptoms in Young Adults Born Preterm with Very Low Birth Weight: Helsinki Study of Very Low Birth Weight Adults